|
|
|
Insider
Information: |
Guiterrez-Ramos Jose Carlos |
Relationship: |
Director |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
402,327 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$3,361,933 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
402,327 |
|
|
Total
Value |
$3,361,933 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
0.0%
|
-6.4%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Synlogic Inc |
SYBX |
Officer, Director |
2017-08-28 |
362,619 |
|
0 |
Premium* |
|
Momenta Pharmaceuticals Inc |
MNTA |
Director |
2020-08-19 |
0 |
2018-06-20 |
0 |
Premium* |
|
Danaher Corp |
DHR |
SVP, Chief Science Off... |
2024-03-01 |
12,958 |
2021-02-24 |
0 |
Premium* |
|
Bicycle Therapeutics Ltd |
BCYC |
Director |
2024-01-02 |
16,750 |
2022-01-03 |
0 |
Premium* |
|
Evelo Biosciences Inc |
EVLO |
Director |
2022-04-01 |
10,000 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
19 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SYBX |
Synlogic Inc |
See RemarksOfficer |
|
2017-08-28 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
362,619 |
|
- |
|
EVLO |
Evelo Biosciences Inc |
Director |
|
2022-04-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
10,000 |
|
% |
|
DHR |
Danaher Corp |
SVP, Chief Science Officer |
|
2022-02-24 |
4 |
D |
$271.56 |
$70,606 |
D/D |
(260) |
2,285 |
0 |
- |
|
DHR |
Danaher Corp |
SVP, Chief Science Officer |
|
2023-02-24 |
4 |
D |
$249.12 |
$119,827 |
D/D |
(481) |
4,014 |
0 |
- |
|
DHR |
Danaher Corp |
SVP, Chief Science Officer |
|
2023-05-01 |
4 |
S |
$242.19 |
$121,096 |
D/D |
(500) |
7,529 |
0 |
% |
|
DHR |
Danaher Corp |
SVP, Chief Science Officer |
|
2023-08-21 |
4 |
S |
$250.54 |
$147,819 |
D/D |
(590) |
6,939 |
0 |
% |
|
DHR |
Danaher Corp |
SVP, Chief Science Officer |
|
2024-02-26 |
4 |
D |
$253.84 |
$219,825 |
D/D |
(866) |
10,026 |
0 |
- |
|
DHR |
Danaher Corp |
SVP, Chief Science Officer |
|
2022-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
2,210 |
4,495 |
0 |
- |
|
DHR |
Danaher Corp |
SVP, Chief Scientific Officer |
|
2021-02-24 |
4 |
A |
$223.00 |
$567,535 |
D/D |
2,545 |
2,545 |
0 |
- |
|
DHR |
Danaher Corp |
SVP, Chief Science Officer |
|
2024-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,932 |
12,958 |
0 |
- |
|
DHR |
Danaher Corp |
SVP, Chief Science Officer |
|
2024-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
3,155 |
10,892 |
0 |
- |
|
DHR |
Danaher Corp |
SVP, Chief Science Officer |
|
2023-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
4,015 |
8,029 |
0 |
- |
|
MNTA |
Momenta Pharmaceuticals I... |
Director |
|
2019-06-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,356 |
10,090 |
0 |
- |
|
BCYC |
Bicycle Therapeutics Ltd |
Director |
|
2022-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
0 |
- |
|
MNTA |
Momenta Pharmaceuticals I... |
Director |
|
2018-06-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,734 |
5,734 |
0 |
- |
|
BCYC |
Bicycle Therapeutics Ltd |
Director |
|
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
5,750 |
10,750 |
0 |
- |
|
BCYC |
Bicycle Therapeutics Ltd |
Director |
|
2024-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
16,750 |
0 |
- |
|
MNTA |
Momenta Pharmaceuticals I... |
Director |
|
2020-08-19 |
4 |
AS |
$52.09 |
$520,900 |
D/D |
(10,000) |
0 |
0 |
% |
|
MNTA |
Momenta Pharmaceuticals I... |
Director |
|
2020-08-19 |
4 |
OE |
$8.59 |
$85,900 |
D/D |
10,000 |
10,000 |
0 |
- |
|
19 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|